2020 Final Resolution: Day 1
Finalized Resolution
IOWA HIGH SCHOOL MODEL UNITED NATIONS
IOWA YOUTH SYMPOSIUM
Resolution (2020)
Adopted on: Tuesday, October 20th at 2:10 PM
Resolution created by the Science Committee
Regarding: Vaccine Development and Distribution
Preambulatory Clauses:
RECOGNIZING a vaccine is a type of medicine that is injected into someone to build immunity to a virus, bacteria, or disease, and
ACKNOWLEDGING that the World Health Organization has taken action to promote vaccinations on most accounts in the past, and
BEARING IN MIND Vaccines don't always prevent virus but help lower symptoms, and
ACKNOWLEDGING the devastating effect lack of funds can produce on the development of vaccines and stopping the spread of viruses, and
BEARING IN MIND that vaccination, as supported by the WHO and partners, has reduced Polio by 99 percent, and
ACKNOWLEDGING the recovery rate of Covid-19, and
EXPRESSING appreciation for the professionals working on vaccines, and
NOTING WITH DEEP CONCERN that some countries are risking the safety of their people and the safety of the vaccines themselves to try and fast track them, and
Aware that the FDA has approved fast-tracking for certain COVID-19 vaccines, and
RECOGNIZING medical companies have received funding for vaccine development, and
RECOGNIZING vaccine development usually has several different stages, the exploratory stage, pre-clinical stage, clinical development, regulatory review and approval, manufacturing, and quality control, and
ACKNOWLEDGING in 1974 the World Health Organization (WHO) established the Expanded Program on Immunization (EPI). This program included routine infant immunizations for tuberculosis, poliomyelitis, diphtheria, tetanus, pertussis, and measles, and
AWARE OF the speed Covid-19 vaccines are being developed, and
AFFIRMING it is crucial to execute enough clinical testing on a vaccine in order to ensure the saftey of the population receiving the vaccine, and
COGNIZANT THAT competition between pharmaceutical companies may create irresponsible haste in vaccine development, and
ACKNOWLEDGING that vaccines are often required to be held at very low temperatures with little tolerance, and
FULLY AWARE that the US federal government has donated over $9 Billion USD to 7 companies for vaccine development and research, and
ACKNOWLEDGING The importance of vaccines for public safety and extending life expectancy, and
AWARE OF the negative effects not having access to vaccines has on communities and the human population, and
AWARE OF the substantial amount of developed vaccines that have had to be disposed of because they were not kept at the appropriate temperatures, and
MINDFUL OF the importance of the chain of supply and the demands of cold temperatures, glass holding vials, and syringes, and
COGNIZANT OF the large cost of vaccines and the money that must go into producing them, and
Actuating Clauses:
CALLS UPON the United Nations to allocate funds from budget to create a monetary safety net that supports vaccine development done by accredited institutions and further funds efforts to secure the chain of supply for developing countries, and
ENCOURAGES low pricing on vaccines in order to ensure companies are developing vaccines for the better good rather than financial gain, and
EMPHASIZES the importance for nations to continue work on distributing vaccines to needed areas quickly and effectively, and
RECOMMENDS that groups such as the WHO and the ICG continue to receive support from the UN, and
ENCOURAGES the world health community to consider nations' ability to properly handle and distribute vaccines when determining which nations receive early vaccines, and
RECOMMENDS placing UN organizations such as the WHO and COVAX in charge of vaccine distribution, and
ENCOURAGES countries to distribute vaccines to medical workers, elderly, and people with underlying health conditions first when Covid-19 vaccine becomes approved by FDA and CDC, and
CALLS UPON member nations and vaccine developers to prioritize safety and precaution over haste in vaccine development and testing, and